Recombinant Human FABP1 Protein，His

Fatty Acid Binding Protein 1 (FABP1), a member of the FABP family, plays a critical role in the intracellular transport and metabolism of fatty acids, influencing various physiological processes, including lipid metabolism and insulin sensitivity. Studies have shown that FABP1 is primarily expressed in the liver and is involved in the regulation of lipid homeostasis and inflammation. Its significance extends beyond basic metabolism, as altered FABP1 expression is associated with metabolic disorders, such as obesity and type 2 diabetes. Researchers are increasingly interested in recombinant FABP1 proteins for their potential applications in drug development and therapeutic strategies, as well as their utility in unraveling the intricate molecular mechanisms underlying fat metabolism. Recombinant production of FABP1 has made it possible to explore its structure-function relationships, enabling detailed studies on how FABP1 interacts with fatty acids and other cellular targets. Understanding these interactions may lead to the identification of novel biomarkers for metabolic diseases and facilitate the design of targeted therapies aimed at combating disorders linked to dysregulated lipid metabolism. Furthermore, FABP1's role in cellular signaling pathways highlights its potential as a therapeutic target, making recombinant FABP1 an important focus of current biomedical research aimed at addressing global health issues related to obesity and metabolic syndrome. As such, the elucidation of FABP1's functions through recombinant protein studies represents a promising frontier in the quest to develop innovative interventions for metabolic diseases.